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Lately, the cosmetic and personal caremarket has beenmore andmore driven toward natural
ingredientsby the risingconsumers' awareness aboutpersonal health and safetyand theirwill
for safer cosmetics free of harmful chemicals. Preservatives are no exception to the rule: evi-
dence or suspicion of the toxicity of certain synthetic preservatives that have been around for
decades pushed the cosmetic industry forward to seek for natural alternatives, as the selection
of natural preservatives already available is quite limited. Sourcing active metabolites and
developing new natural ingredients are long-term procedures that are thoroughly described
in the present paper, via the example of the design of a natural preservative based on the
Santolina chamaecyparissus extract, and of the assessments of its preservative effectiveness.
© 2016 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).r é s u m é
Recemment, sous la pression grandissante de consommateurs toujours plus avertis en
matiere de sante publique, le marche de la cosmetique s'est tourne vers les ingredients
naturels aﬁn de formuler des produits cosmetiques plus sûrs et denues autant que faire se
peut de produits chimiques dangereux. Les conservateurs ne constituent pas une exception :
les suspicions et preuves de toxicite de certains conservateurs de synthese, pourtant utilises
depuis des decennies, ont impulse la recherche en matiere de solutions alternatives
naturelles, etant donne qu’a l'heure actuelle le choix en matiere de conservateurs naturels
est encore restreint. Le sourcing de metabolites secondaires et le developpement de nou-
veaux ingredients naturels, procedures de longue haleine, sont decrits dans cet article, a
travers l'exemple du developpement d'un conservateur naturel a base d'extrait de Santolina
chamaecyparissus et de l’evaluation de ses proprietes conservatrices.
© 2016 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).(A. Kerdudo), Pauline.BURGER@unice.fr (P. Burger), ﬂorence.merck@live.fr (F. Merck), adingas@
m (Y. Rolland), Thomas.MICHEL@unice.fr (T. Michel), Xavier.FERNANDEZ@unice.fr (X. Fernandez).
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The worldwide cosmetic industry has largely developed
over the past decade (worth expected to reach $390 billion
by 2020; [1]) and its solid growth continues to be driven
essentially by consumers expecting increasingly innovative
products, as well as efﬁcacy and quality. However, rising
awareness about personal health and safety also led the
consumers to look forward to safer cosmetics free of
harmful chemicals. Hence, the dramatically increasing
global trade in natural ingredients sourced from vegetable,
mineral or marine renewable sources has perfectly illus-
trated this important trend in the last years. The predom-
inance of such natural ingredients is largely due to the
various roles they can play in a single cosmetic formula,
acting as active ingredients (e.g., moisturizers), excipients
(e.g., surfactants), additives (e.g., preservatives), etc., the
last ones being particularly sought for by cosmetic
manufacturers.
Microbial growth could occur in cosmetics and per-
sonal care products under usual manufacturing and usage
conditions and numerous sources of contamination have
been identiﬁed: the raw materials, the packaging, or even
the manufacturing processes and environments that are
often not sufﬁciently sterile. These products can also be
exposed to temperature variations, and be notably subject
to temperatures higher than recommended in shops and
consumers' bathrooms, hence increasing the micro-
organism growth rate. Furthermore, once the cosmetic or
personal care product is opened, and until it is discarded,
it is highly susceptible to further contamination due to
consumer use (constant dipping of non-sterile ﬁngers in
the product, contact with non-sterile bodies, etc.). Micro-
organisms can hence easily multiply and cause unpleas-
ant discolouration and odour, and can degrade active
compounds in products, leading to the instability of
ﬁnished products [2,3]. Cosmetics and personal care
products are hence expected to resist microbial attack
within their intended period of use [4]: preservatives are
then necessary to prevent product spoilage and subse-
quently consumers' infections caused by harmful micro-
organisms. Strict rules govern the inclusion of
preservatives in cosmetics. Throughout Europe, manufac-
turers must carefully choose among preservatives listed in
Annex V of Regulation (EC) [4] that have previously been
subjected to scientiﬁc tests and approval procedures:
every cosmetic formulation requires a tailor-made pre-
servative system to meet its speciﬁc needs (selection of
the appropriate nature and dosage of a speciﬁc preserva-
tive) [5].
Synthetic preservatives employed over decades such as
p-hydroxybenzoic acid, phenoxyethanol and imidazoli-
dinyl urea [3], display a whole lot of beneﬁts including
notably their more than affordable price, their broad-
spectrum of activity against bacteria and fungi, their
compatibility with other ingredients, and the fact that they
generally do not interfere with fragrance, colour, or other
aspects of a given formulation. However, although common
synthetic preservatives do extend the lifespan of the
products and help to keep them free from micro-
organisms, many of them have developed negativereputations in consumers' minds and their use has become
more and more controversial over the last years. In fact,
often petroleum-based, they can be unhealthy and can
notably promote irritations or infections, particularly on
damaged skin, or the sensitive areas around the eyes [6].
Some of them can even cause higher health issues: 4-
hydroxybenzoic acid esters, better known as parabens
have been themost widely used preservatives (entering the
composition of about 80% of the worldwide cosmetics; [7]),
but have recently been reported to mimic oestrogen, to
increase female breast cancer incidence and to inﬂuence
the development of malignant melanoma [8]. Following
the controversies about parabens and phenoxyethanol,
cosmetic formulators are under increased pressure to turn
more and more to innovative natural ingredients [7],
because they are not only healthier alternatives for con-
sumers but they also provide a wonderful marketing angle.
In fact, the discovery and usage of a natural ingredient with
preservative properties offers cosmetic industries the
chance to communicate about the “preservative free”
aspect of their products, as these new natural ingredients
do not fall under the legislation and are hence not listed
among preservatives in Annex V of Regulation (EC) [4].
Furthermore, if such a natural ingredient, besides its pre-
servative action, also displays another interesting property,
e.g., anti-oxidizing effect, the marketing communication
opportunities will become even larger. Finally, rising con-
sumer demand for products formulated with natural raw
materials also offers cosmetic companies a chance to raise
the awareness of consumers to biodiversity that becomes a
strategic issue as a rich source for innovative molecules.
Sourcing new natural ingredients engage cosmetic in-
dustries in a ‘green economy’ policy presided over by the
respect of the principles of the Nagoya Protocol introduced
on 29 October 2010, and issued from a number of imple-
ments of the original Convention on Biological Diversity
(CBD) ratiﬁed in 1992 by 168 States at the United Nations'
Earth Summit held in Rio de Janeiro [9]. The CBD consti-
tuted the ﬁrst international document to recognize the
urgent need to protect biodiversity, the sustainable use of
its resources, and the equal and rightful sharing of the
beneﬁts it represents. Application of high throughput
screening technologies to natural product samples accel-
erates the discovery, development and use of natural in-
gredients but such a screening is still a long-term
undertaking as only ﬁve in every 100 genetic resources
identiﬁed as being potentially of interest will ever end up in
cosmetic and personal care formulae as they also have to
pass all the efﬁcacy, quality and safety tests right
throughout the development chain [10].
Regions presenting high biodiversity and a high per-
centage of endemic ﬂora and fauna that are especially
endangered are recognized as biodiversity hotspots
[11,12] and constitute protection priorities. With the
generalized awareness of this richness threatened with
extinction it appeared worth preserving this biodiversity
and valuing plant species in the form of new ingredients
intended notably for cosmetic and pharmaceutical in-
dustries. The Mediterranean region was identiﬁed as one
of these biodiversity hotspots [12] due to its remarkable
ﬂora and specially its high rate of endemic species:
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houses 20% of the world's total ﬂoristic richness [13,14].
This Mediterranean biome hence constitutes a choice
target to source natural products intended both for cos-
metics and drug design.
Considering this, 50 Mediterranean plants were initially
selected from over 2000 for the present study, based on a
literature survey and on the basis of their traditional use: 17
of them were accessible for further evaluation of their po-
tential use as preservatives in cosmetics. A screening of
their antimicrobial activities was engaged and the optimi-
zation of the most interesting crude extract was then
investigated for practical cosmetic formulation.
2. Results and discussion
2.1. Antimicrobial activity screening
A screening of the antimicrobial activities of 17 of the 50
plants initially selected was undertaken to pinpoint plants
presenting potential as cosmetic preservatives. For this,
solvent crude extracts were prepared at respectively 2%
(massic concentration in the raw extract; results displayed
in Table 1) and 0.2% (data non shown): EtOH/H2O 75:25 (v/
v) extracts were preferentially tested because such a sol-
vent system is non-toxic and enables the extraction of a
broad range of metabolites. Their antimicrobial activity wasTable 1
Antimicrobial activity screening of Mediterranean plant extracts.
Plant name Plant part Localization Ext
solv
Cistus albidus L. Twigs 1 70%
Pistacia lentiscus L. Twigs 1 70%
Salvia verbenaca L. Aerial parts 1 70%
Ruta chalepensis L. Aerial parts 1 75%
Coronilla emerus L. Flowered aerial parts 2 75%
Laurus nobilis L. Twigs 1 75%
Rosmarinus ofﬁcinalis L. Flowered branches 4 75%
Thymus vulgaris L. Flowered aerial parts 5 75%
Santolina chamaecyparissus L. Flowered aerial parts 2 75%
Juniperus oxycedrus L. Twigs 5 75%
Juniperus communis L. Branches bearing fruits 5 75%
Myrtus communis L. Flowered aerial parts n.c. 75%
Hypericum perforatum L. Flowered aerial parts n.c. 75%
Cupressus sempervirens L. Twigs n.c. 75%
Alliaria petiolata (M. Bieb.)
Cavara & Grande
Aerial parts 6 75%
Helichrysum stoechas L. Aerial parts 7 75%
Satureja montana L. Flowered aerial parts 8 75%
Positive standard (methylparaben
tested at 0.4%)
/ / /
Ysaline e red algae extract
(100 mg/ml)
/ / EtO
Totarol e Podocarpus totarol
extract (100 mg/ml)
/ / EtO
Localization codes: one Departmental park Estienne d’Orves (Alpes-Maritimes)
four St Jeannet (Alpes-Maritimes), ﬁve Rimplas (Alpes-Maritimes), six Brenon (V
eight Isola 2000 (Alpes-Maritimes), n.c.: not communicated.
Light grey: commercial natural extracts with preservative properties.
(þþþ): 90%  inhibition 100%; (þþ): 70%  inhibition 90%; (þ): 60%  inhi
Bold row corresponds to the selected active extract.evaluated in compliance with the regulation against the
yeast Candida albicans, the ﬁlamentous fungus Aspergillus
niger and the bacteria Staphylococcus aureus and Pseudo-
monas aeruginosa, using 96-well microplate assays based
on microbial growth inhibition assessed after respectively
24 and 48 h for yeast and fungus, and 48 and 72 h for
bacteria. Tests were performed on several extracts from
plants collected at different seasons over a 2e3 years
period, and the results shown in Table 1 represent the
mean activity of each extract.
As shown in Table 1, almost all of the tested extracts
display good to excellent S. aureus growth inhibition ac-
tivities. On the contrary, only the Pistacia lentiscus extract
(EtOH/H2O 70:30 v/v) seems to present a good activity
against the growth of P. aeruginosa after 48 h.
Interesting activities against the three remaining micro-
organisms have been observed for the Laurus nobilis L. and
Hypericum perforatum L. extracts (EtOH/H2O 75:25 v/v).
The prominent antibacterial activity of the ethanolic
extract of L. nobilis L. fresh leaves and twigs was already
assessed [15]. Similarly, the effective antibacterial activity
of the methanolic extract of L. nobilis L. seed oil was
observed by Ozcan et al. [16] and one of the supercritical
ﬂuid extracts of L. nobilis L. leaves was observed by Santoyo
et al. [17]. In a similar way, the antibacterial activity of
various extracts of H. perforatum L. has already been
assessed [18e20].raction
ent
Antimicrobial activity at 2%
P.
aeruginosa
S. aureus A. niger C. albicans
48 h 72 h 24 h 48 h 48 h 72 h 24 h 48 h
EtOH  ~ þþþ þþ þþþ ~ þþ ~
EtOH þþ ~ þþ þþ ~   
EtOH   þþ  þ   
EtOH   þþþ þþþ þþ þ ~ ~
EtOH   þþ  þþ þ  
EtOH   þþþ þþþ þþþ þþþ þþþ þþþ
EtOH   þþþ þþþ ~ ~  
EtOH   þþþ þþþ þþþ ~  þ
EtOH   þþþ þþþ þþþ þþþ þþ ~
EtOH ~ þ þþþ þþþ þþþ ~ þ ~
EtOH   þþþ þþþ þ   
EtOH   þþ þþþ þþ  þ ~
EtOH   þþþ þþþ þþþ þþþ þþþ þþþ
EtOH   þþþ þþþ    
EtOH   þþþ þþþ    
EtOH   þþþ þþþ ~   
EtOH        
þþþ þþþ þþþ þþþ þþþ þþþ þþþ þþþ
H/H2O 60/40        
H/H2O 60/40 þþ þþ þþþ þþþ þþ þþ  
, two Cabris (Alpes-Maritimes), three Roussillon (Tinee valley, Vaucluse),
ar), seven Var bed (at the conﬂuence with the Vesubie, Alpes-Maritimes),
bition 70%; (~): 40%  inhibition 60%, (): inhibition 40%.
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aerial parts of Santolina chamaecyparissus display the best
unprecedented results against these micro-organisms (in-
hibition superior to 90% of the growth of C. albicans, A. niger
and S. aureus), except for P. aeruginosa.
S. chamaecyparissus L., commonly known as cotton lav-
ender, is a species of ﬂowering plant belonging to the
Asteraceae family. It is native to Southeastern (Croatia and
Italy) and Southwestern Europe (France and Spain) and is
mainly used as an ornamental plant [21].
This extract was analysed by using a High Performance
Liquid Chromatography-Diode array Detector-Evaporative
Light Scattering Detector (HPLC-DAD-ELSD; Fig. 1): be-
sides polar (e.g., sugars and amino acids) and some hy-
drophobic compounds, this extract is mainly constituted by
ﬂavonoids and spiroketal derivatives, amongwhich amajor
unknown compound eluting after 26 min is detected. This
extract was then selected for further investigation and
optimization for practical cosmetic formulation.2.2. Bioguided fractionation of the S. chamaecyparissus
extract
In order to identify the active compounds, the EtOH/H2O
75:25 (v/v) extract of S. chamaecyparissus was then frac-
tionated over silica gel (normal phase). The fractionation of
2.2 g of the bulk extract led to the recovery of ﬁve distinct
fractions: F1 (cyclohexane; 8 mg), F2 (cyclohexane/AcOEt
1/1; 249 mg), F3 (AcOEt; 88 mg), F4 (EtOAc/MeOH 1/1;
781 mg) and F5 (MeOH; 412 mg).
The resulting fractions were further evaluated for their
antimicrobial activity. Fraction solutions were concentrated
at 100 mg/mL in DMSO and their activities were assessed
the same way as one of the crude extracts.
Table 2 shows the inhibition percentages of the ﬁve
resulting fractions against four bacteria, yeast and fungi at a10 20 30
0
250
500
750
1000
1250
1500
1750
Flavonoids and spiroketal derivatives
*Unknown compound
*
Sugars
Amino acids
Fig. 1. HPLC-DAD-ELSD proﬁle of the crude extract of S. chamaecypconcentration of 0.4% (w/v) (the results obtained for the
extract at a concentration of 0.04% are not shown in the
present article). Methyl-paraben at 0.4% (w/v) was used as
the positive control.
No activity was observed for the cyclohexane (F1) and
MeOH fractions (F5). The EtOAc/MeOH fraction (F4) was
only active at 0.4% (w/v) against A. niger (inhibition per-
centage higher than 60%). The ethyl acetate fraction (F3)
was signiﬁcantly active at 0.4% (w/v) against A. niger and C.
albicans, but no activity was observed against P. aeruginosa
and S. aureus.
Finally, the cyclohexane/AcOEt fraction (F2) was the
most interesting one, exhibiting a strong antimicrobial ac-
tivity against the four evaluated strains over 48 h (C. albi-
cans and S. aureus) and over 72 h (P. aeruginosa and A.
niger).2.3. Isolation and identiﬁcation of the active metabolite
HPLC-DAD-ELSD analysis of both the crude extracts of S.
chamaecyparissus and the ﬁve resulting fractions showed
the presence of a major metabolite in F2 (Fig. 2) that is ab-
sent in other fractions: thismajormetabolitewas suspected
to be responsible for the antimicrobial activity of S. cha-
maecyparissus crude extracts or at least a contributor to it.
Semi-preparative HPLC was then performed on this
active fraction in order to conﬁrm this assumption: multi-
ple injections of this fraction concentrated at 50 mg/mL
were carried out and 9 mg of the molecule were obtained.
Its molecular formula C15H12O4 was deduced from
UPLC-ESI-HRMS experiments ([MþH]þ m/z 257.0816,
C15H13O4). The UV spectrum showed the band of maximum
absorption centred at 310 nm.
1H and 13C NMR, associated with COSY, HSQC and
HMBC experiments revealed the presence of an acetoxy
group, as suggested by the signal at dH 2.1 (3H,s, H-15),40 50
300 nm
0
50
100
150
200
250
300
Hydrophobic compounds (triterpenoids)
arissus showing the major families of metabolites identiﬁed.
Table 2
Antimicrobial activities of the S. chamaecyparissus crude extract and of the resulting F1eF5 fractions compared to those of a commercial preservative.
Sample Strains Growth inhibition at 0.4% Average inhibition
24 h 48 h 72 h
Crude extract of S. chamaecyparissus A. niger 102 101 þþþ
C. albicans 100 100 þþþ
P. aeruginosa 1  
S. aureus 97 98 þþþ
F1 A. niger   
C. albicans   
P. aeruginosa   
S. aureus   
F2 A. niger 100 100 þþþ
C. albicans 99 98 þþþ
P. aeruginosa 94 90 þþþ
S. aureus 105 113 þþþ
F3 A. niger 90 103 þþþ
C. albicans 96 44 ~
P. aeruginosa 6  
S. aureus  15 
F4 A. niger 68 7 ~
C. albicans 17 13 
P. aeruginosa 13 8 
S. aureus 36 56 ~
F5 A. niger 0 4 
C. albicans   
P. aeruginosa  21 ~
S. aureus 32 30 ~
Methylparaben A. niger 100 100 þþþ
C. albicans 99 100 þþþ
P. aeruginosa 75 81 þþ
S. aureus 80 93 þþ
(þþþ): average inhibition 90%; (þþ): 70%  average inhibition 90%; (þ): 60%  average inhibition 70%; (~): 20%  average inhibition 60%, ():
average inhibition 20%.
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signals suggested the presence of a polyacetylene chain
(C2eC3eC4eC5) while the four quaternary carbons pre-
sent a dC from 64.8 to 80.5; the interpretation is further
conﬁrmed using HMBC. Complete correlations are pre-
sented in Table 3. The structural analyses enabled the
identiﬁcation of (5S,7Z)-7-(hexa-2,4-diyn-1-ylidene)-1,6-
dioxaspiro[4.4]nona-2,8-dien-4-yl acetate, from the pol-
yacetylene family, already found in Santolina species
(Fig. 3) [22e25]: commonly named spiroketalenol, it is
referred to as SKE in the present article. No mention of
any kind of the assessed antimicrobial activity was re-
ported for this substance in the literature.2.4. SKE antimicrobial activity
Pure SKE appeared to be unstable once isolated,
particularly in aqueous and acidic conditions. Since anti-
microbial assays are performed in water, its antimicrobial
activity could not be directly evaluated as for crude plant
extracts or fractions. Thus there was a need to develop a
methodology to establish a relationship between the bio-
logical activity of crude extracts and their SKE content.
Such a quantitation of SKE was performed by HPLC-UV
at 310 nm (SKE absorption maximum): a calibration curve
was constructed using (E)-cinnamic acid as a standard and
the active substance concentration was expressed as mg
equivalent of (E)-cinnamic acid per gram of the crude
extract.Once the SKE concentrations in various extracts were
determined, the corresponding antimicrobial activities
were assessed. As shown in Table 4, a relationship between
the SKE concentration and the antimicrobial activity,
especially against A. niger and C. albicans can be evidenced:
no activity against these two strains was detected when no
SKE was quantiﬁed in the extract. On the contrary, as the
SKE concentration increases, antimicrobial activity is
observed and appears to be maximal when the SKE con-
centration is higher than 9.1 mg equiv/g of the extract.
However, the activity against S. aureus seems to be in-
dependent of the SKE presence: in fact, almost all the ex-
tracts containing SKE or not were active against this strain.
Finally, it was highly difﬁcult to conclude about the ac-
tivity against P. aeruginosa as only one extract containing
SKE at 17.6 mg equiv/g was active against this last strain.2.5. Stability assessment
The instability of isolated SKE has already been stated; it
appeared crucial to test its stability in the S. chamaecypar-
issus extract incorporated into a cosmetic formulation
before any further ingredient development.
Creams formulated with 0.5 (data not shown) and 2% of
the S. chamaecyparissus extract together with various
cosmetic supports were then subjected to stability tests:
these cosmetic products were kept either at room tem-
perature or at 42 C for 13 weeks. The evolution of the SKE
concentration in these ﬁnished products was followed by
Crude extract
F1 - Cyclohexane
F2 - Cyclohexane/EtOAc 1/1
F3 - EtOAc
F4 - EtOAc/MeOH 1/1
F5 - MeOH
Fig. 2. HPLC-ELSD proﬁles of the crude extract of S. chamaecyparissus and the resulting F1eF5 fractions.
O
A. Kerdudo et al. / C. R. Chimie 19 (2016) 1077e10891082HPTLC, using an appropriate mobile phase to properly
separate SKE from the other ingredients (retention factor
Rf¼ 0.42).
A stability test was performed over 6 weeks at room
temperature; then one week later (day 49), the formulated
creams were either stored at room temperature or at 42 C.Table 3
1H and 13C NMR chemical shifts and multiplicity.
C dC (ppm) C dH (ppm) Multiplicity
1 4.8 CH3 2.0 s
2 80.5 Cq e e
3 64.8 Cq e e
4 77.7 Cq e e
5 70.3 Cq e e
6 83.1 CH 5.1 br s
7 168.9 Cq e e
8 133.8 CH 6.3 dd (J¼ 5.7 ; J¼ 1.6 Hz)
9 126.1 CH 6.8 d (J¼ 5.7 Hz)
10 117.3 Cq e e
11 148.6 CH 6.6 d (J¼ 3.0 Hz)
12 100.8 CH 5.2 dd (J¼ 2.5 Hz; J¼ 3.0 Hz)
13 75.2 CH 5.7 d (J¼ 2.5 Hz)
14 170.5 Cq e e
15 20.5 CH3 2.1 s
O O O
Fig. 3. Spiroketalenol structure (thick bonds correspond to COSY
correlations).As shown in Fig. 4, the SKE concentration remained stable
at room temperature with the three cosmetic supports
tested. However, SKE degradation was observed in a cream
placed at 42 C after 7 weeks at room temperature (only
40% of SKE wasmeasured in the cream after 20 weeks): one
can suggest that SKE, stable at room temperature, is heat
sensitive, but further investigations should conﬁrm this
observation and appropriate storage conditions could be
deﬁned.
Table 4
SKE concentrations (mg equiv. cinnamic acid/g of extract) and antimicrobial activities of S. chamaecyparissus crude extracts as functions of harvesting place
and period.
Crude extracts SKE concentration (mg equiv/g of extract) Antimicrobial activity
Harvesting place Harvesting period P. aeruginosa S. aureus A. niger C. albicans
HP1 06/2010 7.9  þ þ 
HP1 02/2011 1.1  þ þ þ
HP1 03/2011 0.4  þ  þ
HP1 06/2011 0.2  þ  
HP2 06/2011 1.4  þ  þ
HP2 02/2012 9.1  þ þ þ
HP2 09/2012 17.6 þ þ þ þ
HP2 03/2013 9.3  þ þ þ
HP3 04/2011 0.3   ~ 
HP4 06/2011 0.0  þ  
HP4 07/2011 0.0  þ  
HP5 12/2012 5.8  þ þ 
Fig. 4. Evolution of the SKE content in creams formulated with 2% of the S. chamaecyparissus extract and subjected to stability tests.
A. Kerdudo et al. / C. R. Chimie 19 (2016) 1077e1089 1083Furthermore, it would be necessary to push these sta-
bility tests forward once the deﬁnite formulation has been
determined: tests at room temperature and at 42 C should
be supplemented with tests in an ageing chamber where
the effect of temperature variations mimicking the ones a
ﬁnished product is subjected to, from formulation to con-
sumer's use, could be monitored.
2.6. Natural ingredient design
Once the stability of the active molecule has been
established in cosmetic formulae, the corresponding nat-
ural cosmetic ingredient can be developed.
The necessary requirements for such a development are
quite numerous, as evidenced in Fig. 5: natural substances
that show antimicrobial activity are usually not directly
incorporable into a formulation as they may display un-
desirable qualities.
First, there is a necessity to respect the integrity of the
active molecule during the extraction process, and henceto optimize this extraction process via the development
of an appropriate non-toxic extraction solvent system or
via the use of modern extraction techniques such as mi-
crowave assisted extraction, ultrasonic assisted extraction
or supercritical ﬂuid extraction. Secondly, some sub-
stances may display offensive odours and/or colours that
would be unacceptable in skin care products [7] and
therefore need to be subjected to further processing,
including notably a discolouration procedure. Finally, the
addition of a cosmetic support, either liquid or solid, may
be necessary to facilitate its incorporation into a cosmetic
formulation.
As the antimicrobial activities appeared to be correlated
with extract's SKE concentration, optimization of the
extraction process was in the ﬁrst place performed via the
modiﬁcation of the solvent system used. Several extraction
replicas were performed using each solvent system tested
to testify individual repeatability: the extraction repeat-
ability was good as the mean standard deviation per sol-
vent system never exceeded 10%.
Fig. 5. Strategy adopted to develop a natural cosmetic ingredient, from plant sourcing to formulation.
Table 5
SKE concentrations (mg equiv cinnamic acid/g of extract) as a function of
extraction solvent system.
Extraction solvent SKE concentration (mg equiv/g)
Absolute EtOH 8.5
EtOH 96% 15.0
EtOH/H2O 80:20 19.9
EtOH/H2O 60:40 2.9
EtOH/H2O 40:60 0.3
EtOH/H2O 20:80 0.0
H2O 0.0
MeOH 44.3
EtOAc 20.3
THF 12.0
Acetone 31.0
DCM 40.8
MethylTHF 16.4
Bold corresponds to the most active extracts. EtOH: Ethanol, H2O: Water,
MeOH: Methanol, DCM: Dichloromethane, EtOAc: Ethyl acetate, THF:
Tetrahydrofurane.
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formed, testing gradients ranging from 100% EtOH to 100%
H2O. As shown in Table 5, the highest SKE concentration
(19.9mgequiv/g)was obtainedusing EtOH/H2O80:20 (v/v).
The more the water ratio in the extracting solvent system
increased, the weaker the SKE concentrationwas. Similarly,
using absolute EtOH rather than EtOH 96% leads to a
decrease in the SKEconcentration.Anoptimal ratiowas thus
established containing between 60 and 96% EtOH (v/v).
Other solvents were also compared to the extract of
the plant. Methanol appears to be the extraction solvent
giving the highest concentration of metabolite (44.3 mg
equiv/g). Dichloromethane, acetone and ethyl acetate
were also good candidates for the extraction of S. cha-
maecyparissus (40.8, 31.0 and 20.3 mg equiv/g, respec-
tively). All these four solvents gave higher active
concentration than ethanol/water 80:20. Methanol was
subsequently selected for the following optimization of
the extraction process to produce a cosmetic ingredient
based on the S. chamaecyparissus extract [26]. However,
caution should be taken as methanol as well as
dichloromethane is CMR (carinogenic/mutagenic/repro-
toxic) solvent, and its use in the extraction of the
cosmetic ingredient is highly contraindicated and shall be
progressively banned: any residual trace of extraction
solvent in the ﬁnished product is scrutinized [27e29].
The antimicrobial activity of the methanolic extract was
tested (see Table 6): a signiﬁcant activity was observed
against S. aureus, A. niger and C. albicans, whereas only a
moderate activity was noted against P. aeruginosa and no
activity at all was observed against Escherichia coli at 0.4%.As already stated, the presence of pigments (e.g., chlo-
rophylls, anthocyanins, etc.) in solvent crude extracts
dedicated to the development of cosmetic ingredients is
unacceptable. Discolouration of such extracts can be per-
formed using either activated carbon or molecular distil-
lation. Both techniques were tested in the second phase of
the optimization of a natural cosmetic ingredient based on
the S. chamaecyparissus extract obtained using EtOH/H2O
80/20 (v/v).
Molecular distillation of cosmetic raw materials enables
removing undesirable odours, colour and some of the
Table 6
Antimicrobial activity of the MeOH extract of S. chamaecyparissus.
Crude extracts Antimicrobial activity at 0.4%
P. aeruginosa S. aureus A. niger C. albicans E. coli
MeOH extract ~ þ þ þ 
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distillation is performed in an extreme vacuum environ-
ment at high temperature for a very short contact time. This
technique was applied on S. chamaecyparissus crude ex-
tracts using liquid medium-chained triglyceridic support:
the resulting liquid product presents a translucent yellow
to orange colour, quite interesting for cosmetic formula-
tion. Unfortunately, once tested for anti-microbial activity,
it appeared that the resulting extract do not display any
interesting microbicidal activity. Furthermore, to perform
such a distillation process, it is necessary to use an almost
non-volatile solvent, traces of which, unacceptable in cos-
metics, are quite difﬁcult to remove thereafter.
Discolouration by adsorption of the undesirable mole-
cule on activated carbon is quite easy as the powdered
activated carbon can easily be added to the liquid extract,
and then removed by settling and ﬁltration. Discolouration
of S. chamaecyparissus crude extracts was performed with
10% of active carbon. The active compound content was
then dosed in discoloured extracts and in almost all cases,
enrichment in SKE was observed as presented in Table 7.
The next step of this optimization procedure consisted
in the addition of an adequate cosmetic support. Malto-
dextrine, a solid cosmetic support, was tested but it appears
that after solvent evaporation, the S. chamaecyparissus ex-
tracts on maltodextrinwere thick and doughy, inducing the
necessity for a tedious solubilization step for subsequent
incorporation into cosmetic formulations. Furthermore,
this support only leads to the “dilution” of extract's anti-
microbial activity, as maltodextrin itself do not display any
interesting microbicidal potential.
Polyols and monoglyceride esters, liquid cosmetic sup-
ports, were then judiciously selected for the development
of such a cosmetic preservative based on the S. chamaecy-
parissus extract, as they present potentially interesting
antimicrobial activity, which could improve the antimi-
crobial activity of the ﬁnal ingredient [7,30e32]. The solu-
bility of the S. chamaecyparissus extract was hence
evaluated in the following cosmetic supports: ethyl-
hexylglycerin (S1), a mixture of ethylhexylglycerin andTable 7
SKE concentrations (mg equiv cinnamic acid/g of extract) in crude and
discoloured extracts.
Crude extracts SKE concentration (mg equiv/g)
Harvesting
place
Harvesting
period
Crude
extract
Discoloured
extract
HP1 04/2012 1.5 20.4
HP1 05/2012 29.4 26.7
HP1 06/2012 18.8 35.8
HP1 12/2012 24.0 51.2
HP1 01/2013 3.2 6.4
HP2 10/2012 5.3 44.0caprylyl glycol (S2), caprylyl glycol (S3), glyceryl caprate
(S4), capryloyl glycine, glyceryl caprylate, glycerin, propyl-
ene glycol, butylene glycol and propanediol. The S. cha-
maecyparissus extract presented the highest solubilities in
S1, S2, S3 and S4, and were only moderately soluble in the
other rawmaterials tested. The ﬁrst three were selected for
further investigations and the resulting ingredients corre-
sponding to the mixture of the crude extract of S. cha-
maecyparissus with either S1, S2 or S3 were subsequently
named ingredient 1 to ingredient 3.
The antimicrobial activities of these three new in-
gredients were tested and compared to one of the crude
extracts alone: results are presented in Table 8. Optimal
activity (>90% of microbial inhibition) was observed for all
ingredients against A. niger. The activity of ingredient 2
appears to be very good (>80% of inhibition) against E. coli
and C. albicans and good (>60% of inhibition) against S.
aureus, whereas it remained optimal with ingredients 1 and
3. Finally, ingredient 1 only displays a medium to poor
activity against P. aeruginosa, whereas ingredient 2 pre-
sents a good one and ingredient 3, an optimal one against
the latter strain.
So, all ingredients evaluated at this step of the study
were highly active against the micro-organisms tested and
were effectively more active than the crude extract alone:
they were then selected for the next steps of the preser-
vative development.2.7. Cosmetic evaluation
The microbial safety of a cosmetic product constitutes a
pre-requisite for its production and commercialization: the
results of challenge tests are required to prove its micro-
biological stability [33].
To comply with this requirement, the three optimized
ingredients were incorporated into various cosmetic for-
mulations (O/W emulsions), one of which is described in
Table 9. The features of the optimized cream were in
accordance with those previously described by Kerdudo
et al. 2015 [34].
Cosmetics containing antimicrobial extracts at concen-
trations ranging from 0.5 to 2.0% were exposed, as recom-
mended by the FDA, to challenge tests to ensure the safety
(e.g., the ability of the preservative system to protect the
product from microbial growth) of both the ingredients
alone and the ﬁnished cosmetic products prior to market-
ing and consumer use. As expected, the control cream, e.g.,Table 8
Antimicrobial activities of the crude extract of S. chamaecyparissus and of
ingredients 1, 2 and 3 (0.4% of extract).
Crude extracts Antimicrobial activity at 0.4%
P. aeruginosa S. aureus A. niger C. albicans E. coli
Crude extract ~ þþþ þþþ ~ 
Ingredient 1 ~ þþþ þþþ þþþ þþ
Ingredient 2 þþ þ þþþ þþ þþ
Ingredient 3 þþþ þþþ þþþ þþþ þþþ
(): inhibition< 60%; (~): 60% but loss; (þ): inhibition 60%; (þþ):
inhibition 80%; (þþþ): inhibition 90%.
Table 9
Cream (O/W) formulation.
Phases Ingredients commercial name INCI name Supplier Quantity (%)
A / Aqua qsp 100
Glycerin 99,5% Glycerin Interchimie 4.00
B Carbopol EDT 2020 Acrylates/C10-30 alkyl acrylate crosspolymer Gattefosse 0.15
C Brij 72 Polyoxyethylene(2) (and) stearyl ether Croda France SAS 2.00
Brij 721P Steareth-21 (and) polyethoxylated alcohol Quimica masso 2.50
Lanette 18 Stearyl alcohol Ami 1.50
Cutina GMS-V Glyceryl stearate Ami 3.00
Eutanol G Octyldodecanol Ami 3.00
Sophiderm Squalane Sophim 2.50
Arlamol HD Isohexadecane Quimica masso 3.00
Virgin jojoba oil Simmondsia chinensis (Jojoba) seed oil Olvea 1.50
Reﬁned wheat germ oil Triticum vulgare (wheat) germ oil Olisud 1.50
Reﬁned shea butter Butyrospermum parkii butter Interchimie 2.00
Silicone oil baysilone M350 Dimethicone Interchimie 1.50
Eusolex 9020 Butyl methoxydibenzoyl-methane IES 1.00
Uvinul MC 80 Ethylhexyl methoxycinnamate IES 1.50
Silicone oil SF1202 Dimethicone Brenntag specialties 2.00
D TEA 99% Triethanolamine Brenntag Co^te d'Azur 0.11
E e Isononyl Isononanoate, Titanium Dioxide e 1.25
F D panthenol 50P Panthenol (and) propylene glycol Laserson 0.20
G Vitamin E acetate Tocopheryl IES 0.50
H Sodium hyaluronate 5.85
I Crude extract of S. chamaecyparissus e e 0.00e2.00
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with the European Pharmacopoeia standards [35]. The
three assays containing 2% of the respective ingredient
produced interesting results. The cream containing ingre-
dient 3 appears to be resistant enough to conform to
criteria A of the European Pharmacopoeia against all mi-
croorganisms [26,35]. Furthermore, the cream containing
ingredient 2 appears to be in compliance with criteria A of
the European Pharmacopoeia against P. aeruginosa, S.
aureus, E. coli and C. albicans and with the criteria B of the
European Pharmacopoeia against Aspergillus brasiliensis.
Finally, the ﬁnished product containing ingredient 1 was
also of interest as it was active against all microorganisms
(criteria A of the European Pharmacopoeia) except against
A. brasiliensis.
These assays were stopped after 14 days of challenge
tests.
3. Materials and methods
3.1. Materials
Water (Chromasolv® for HPLC, purity> 99.8%), aceto-
nitrile (Chromasolv® for HPLC, purity> 99.9%), 2-propanol
(Chromasolv® for HPLC, purity> 99.9%), formic acid
(Puriss, purity> 98%), (E)-cinnamic acid, ethanol, meth-
anol, acetone and dichloromethane were purchased from
SigmaeAldrich (Saint-Quentin Fallavier, France). Deuter-
ated chloroform (CDCl3) for NMR experiments was pur-
chased from Euriso-top (Saint-Aubin, France). Glycerin
(99.5%), butylene glycol and propylene glycol were pur-
chased from Interchimie (Bobigny, France). Sensiva SC50
(ethylhexylglycerin stabilized with vitamin E) and Sensiva
SC10 (caprylyl glycol and ethylhexylglycerin stabilized
with vitamin E) were obtained from Schülke (Gentilly
France). Microcare Emollient CLG (caprylyl glycol) was
distributed by Coptis (Croissy-sur-Seine, France).Dermosoft GMC (glyceryl caprate) and Dermosoft GMCY
(glyceryl caprylate) were purchased from Dr. Straetmans
(Hamburg, Germany). Zemea (propanediol) was obtained
from Dupont Solvents.
3.2. Plant material
All the plants initially selected were collected in 2010 in
the Provence-Alpes-Co^te d’Azur region, in the Alpes-
Maritimes, Var and Vaucluse departments.
Aerial parts of S. chamaecyparissus L. were collected
from Cabris, Isola, Mouans-Sartoux in the Alpes-Maritimes
department, and from Mont Caume and Mont Coudon in
the Var department.
The plant material was botanically authenticated by J.-L.
Polidori and F. Boillot, both botanists, and a specimen of S.
chamaecyparissus L. collected from Mont Caume, Var, in
April 2013 has been deposited at the Regional Botanical
Conservatory of Nice (voucher n C 3746).
3.3. Plant extraction
Aerial parts of S. chamaecyparissus L. were harvested,
dried, ground into powder and extracted under mechanical
stirring using organic solvents. Two consecutive 2 h-ex-
tractions were performed at 25 C and the resulting ex-
tracts were ﬁltered, gathered together and vacuum-
concentrated.
When cosmetic support was added, solvent extraction
wasperformedaspreviously: the rawcosmeticmaterialwas
added before solvent extraction in proportion 1:1 (w/w).
3.4. Sample preparation
Crude extracts and fractions were diluted at 20 mg/mL
in methanol (MeOH) and ﬁltrated over 0.45 mm PTFE sy-
ringe ﬁlter before HPLC analysis.
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dissolved in MeOH at 2 and 20 mg/mL respectively, ultra-
sonicated for 15 min and centrifuged: 2 mL of each super-
natant were systematically applied on the HPTLC plate for
analysis.
3.5. HPLC
Crude extracts and fractions were analysed using an
HPLC Agilent 1200 system (Courtaboeuf, France) equipped
with a DAD and an ELSD operating under the following
conditions: injection volume: 20 mL, ﬂow rate: 1.0 mL/min,
UV-detection performed at 310 nm. The mobile phase
consisted in a gradient of water (A), acetonitrile (B) and 2-
propanol (C), all acidiﬁed with 0.1% acid formic: 0e5 min,
5% B; 5e35min, 5e100% B; 35e45min,100% B; 45e50min,
100e40% B and 0e60% C, 50e60 min, 40% B and 60% C,
60e65 min, 40e5% B and 0e95% A, 65e70 min, 5% B and
95% A.
Quantiﬁcation of the active molecule was performed by
HPLC-UV at 310 nm (wavelength corresponding to the ab-
sorption maximum of the active molecule) under the same
analytical conditions and with the same solvent gradient
(but stopped after 43 min) as the one described previously.
A calibration curve was constructed using (E)-cinnamic
acid dissolved in methanol at concentrations ranging from
0.0078 to 1 mg/mL as a standard. SKE concentrations,
expressed as mg equivalent of (E)-cinnamic acid per gram
of the crude extract, were determined thanks to the linear
regression equation generated by the calibration curve
after integration and area measurement of the corre-
sponding peak in various extracts.
Semi-preparative HPLC of the cyclohexane/ethyl acetate
fraction resulting from the column fractionation of the S.
chamaecyparissus extract (see Compound isolation) was
performed on a Luna C18 column (Phenomenex,
250  10 mm; 5 mm). Elution was performed using a
gradient of non-acidiﬁed water (A) and acetonitrile (B):
0e5 min, 60% B; 5e35 min, 75% B and 35e45 min, 100% B.
3.6. HPTLC
High performance thin-layer chromatography (HPTLC)
was performed on 10 cm  20 cm HPTLC silica (0.20 mm)
gel 60F254 pre-coated glass plates (Merck). Standards and
samples were applied as 8 mm large bands (15 tracks per
plates, 50 nL/s delivery speed), 20 mm from the both plate
edges by means of an automated ATS4 sampler (Camag).
Twomicrolitres of each standard and samples were applied
on silica gel plate. The mobile phase consisted of a solution
of toluene/ethyl acetate/formic acid 98:2:1 (10 ml). The
separation on the silica gel plate was performed in an
automatic ADC2 developing chamber (Camag) with the
tank previously saturated for 20 min with 25 ml of the
developing solvent (humidity previously controlled for
10min: 33e38%). Developing distancewas 70mm from the
lower edge of the plate. Documentation of chromato-
graphic plates (visualization and image capture) was per-
formed at 254 nm, 366 nm and under white light by the TLC
Visualizer documentation (Camag) operated with winCATS
Version 1.4.6 software. Plates were scanned under thefollowing conditions using the TLC scanner 4 controlled by
the WinCATS software: scanning mode, reﬂectance mode
at 315 nm, D2 (deuterium) and W (tungsten) lamps, slit
dimension 8.00 mm  0.40 mm, scanning speed 20 mm/s,
and data resolution 100 mm/step.
SKE presents a good UV absorbance, reaching a
maximum at l at 315 nm, without any co-elution.
The quantiﬁcation of SKE content in formulated creams
was performed via calibration curves constructed with ﬁve
relative concentrations of ingredients 1, 2 and 3 diluted in
MeOH and applied in triplicate on the HPTLC plate (stock
solution prepared at 1 mg/ml; application of respectively, 1,
2, 6, 8 and 12 mL of the corresponding solutions on the
HPTLC plate).
The R2 coefﬁcients were all acceptable above 0.999.3.7. Compound isolation
Open column chromatographic fractionation of the
crude extract was performed using silica gel (normal
phase) and yielded ﬁve fractions: cyclohexane fraction (F1),
cyclohexane/ethyl acetate 1:1 v/v fraction (F2), ethyl ace-
tate fraction (F3), ethyl acetate/methanol 1:1 v/v fraction
(F4) and methanol fraction (F5).3.8. 1H and 13C NMR analysis
NMR analyses were carried out on Bruker Avance
DRX500 (500 MHz) (Brucker, Wissembourg, France).
Mono- (1H and 13C) and bi-dimensional (COSY, HSQC,
HMBC, NOESY) NMR spectra were recorded in CDCl3 at
25 C (Euriso-top, Saint-Aubin, France); chemical shifts (d)
are given in parts per million (ppm), and coupling con-
stants (J) are given in hertz (Hz).3.9. UPLC-ESI-HRMS
UPLC-ESI-HRMS analyses were performed on a QStar
Elite QTOF mass spectrometer (Applied Biosystems SCIEX)
operating under atmospheric pressure ionization, in
positive-ion mode. Samples diluted in methanol at a con-
centration of 1 mg/mL, were eluted on an Acquity UPLC
BEH C18 column (Waters, 100 2.1 mm, 1.7 mm, 35 C); the
ﬂow rate was set at 0.6 mL/min and the injection volume
was 1 mL.
Themobile phase consisted of water (A) and acetonitrile
(B), both acidiﬁed with 0.1% formic acid: 0e5 min, 0% B;
5e10 min, 0e100% B; 10e15 min, 100% B.
Compound 1: Powder, UV lmax (MeOH) 310 nm,
C16H12O4, MW¼ 256.2534, HRMS m/z 257.0816 (calcd for
C16H13O4, 257.0816).
1H NMR (500 MHz, CDCl3) dH 6.8 (d, J¼ 5.7 Hz, 1H), 6.6
(d, J¼ 3.0 Hz, 1H), 6.3 (dd, J¼ 5.7, 1.6 Hz, 1H), 5.7 (d,
J¼ 2.5 Hz, 1H), 5.2, (dd, J¼ 2.5, 3.0 Hz, 1H), 5.1 (br s, 1H), 2.1
(s, 3H) and 2.0 (s, 3H) ppm.
13C NMR (125 MHz, CDCl3) dC 170.5, 168.9, 148.6, 133.8,
126.1, 117.3, 100.8, 83.1, 80.5, 77.7, 75.2, 70.3, 64.8, 20.5 and
4.8 ppm.
Table 10
European Pharmacopoeia criteria (logarithmic reduction as a function of
days D).
European Pharmacopeia
Strains Criteria Logarithmic reduction
D2 D7 D14 D28
Bacteria A 2 3 / NIa
B / / 3 NI
Yeast and molds A / / 2 NI
B / / 1 NI
a NI: No Increase, /: no minimal reduction required.
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The crude extracts (tested at 2% and 0.2%), the subse-
quent fractions (tested at 0.4% and 0.04%) and the in-
gredients (tested at 0.4%) were evaluated for their
antimicrobial activity against the fungus A. niger ATCC
16404, the yeast C. albicans ATCC 10231, the gram() bac-
teria P. aeruginosa ATCC 9027 and S. aureus ATCC and the
gram(þ) bacteria E. coli ATCC 8739 (only the ingredients
were tested over E. coli). Bacterial and yeast trains were
respectively grown in liquid nutrient broth (Difco, Surrey,
England) at 37 C, for 24 and 48 h before antimicrobial
testing.
The assays were performed in 96-well plates as follows:
extract samples were diluted in sterile water. Each concen-
tration was assessed in triplicate with one supplementary
controlwell containingnomicrobial strain. Negative control
was constituted of the solvent mixture used to prepare the
sample solutions, and positive control consisted of methyl-
paraben, a synthetic preservative, at 0.4%. The 96-well
plates were incubated at 37 C, and the optical density (OD)
reading was obtained at 620 nm, 24, 48 and 72 h after the
beginning of the incubation to evaluate inhibition of
microorganism growth. The results were expressed as a
percentage of inhibition according to the formula:
% inhibition ¼ ½ðODðcontrolÞ  ODðsampleÞÞ=ODðcontrolÞ  100
where OD(control) correspond to the optical density read for
the well containing only water and OD(sample) the optical
density read for the well containing the crude extracts, the
subsequent fractions or the ingredients.
3.11. Cosmetic formulation
All the formulations were prepared on a 100 g ﬁnal
mass-basis. Stirring was performed using a propeller mixer
(Turbotest laboratory mixer equipped with an axial ﬂow
propeller, Rayneri, VMI). The cream formulations were
prepared as described by Kerdudo et al. 2015 [34], using the
ingredients listed in Table 9.
3.12. Challenge test
Antimicrobial preservative efﬁciency evaluation was
performed by an external laboratory (Ideatest, Plouzane,
France) following the procedure described in the European
Pharmacopoeia [35].
Five potential pathogenic germs were chosen for this
study (a cosmetic contamination by these microorganisms
could notably cause skin infection or respiratory diseases):
Pseudomonas aeruginosa ATCC 9027, S. aureus ATCC 6538, E.
coli ATCC 8739, C. albicans ATCC 10231 and A. brasiliensis
ATCC 16404 [36]. Tryptic soy agar and Sabouraud dextrose
were respectively used as culturemedia for bacteria and for
yeast/fungus. Cosmetic formulations were sampled in
single-use sterile ﬂasks and every ﬂask was inoculatedwith
strain suspension (at 22.5± 2.5 C in the dark). The inocu-
lation concentration was ﬁxed at 106 CFU/mL, 105 CFU/mL
and 104 CFU/mL respectively, for bacteria, yeast, and fun-
gus. The validation of the neutralization of the preservativewas realized on the ﬁve strains, in the 1/10th and 1/100th
dilution, with LT100 broth. The microbial densities were
counted by inclusion (results in CFU/g or mL), and
compared with the logarithmic reduction criteria of the
European Pharmacopoeia presented in Table 10.4. Conclusion
The present paper presents the development of a nat-
ural preservative for cosmetics, from plant sourcing to the
ﬁnal product formulation and challenge test, via the isola-
tion of the bioactive molecule. When it comes to the
development of new active ingredients for cosmetics,
biodiversity is a rich source for inspiration and innovation,
but as already discussed, such a development is a long-
term and often unrewarding procedure. In fact, only ﬁve
in every 100 genetic resources identiﬁed as being poten-
tially of interest will ever end up in a cosmetic formula once
their efﬁcacy, quality and safety have been established [10].
After antimicrobial activity screening of 17 Mediterra-
nean plants, S. chamaecyparissus was selected and further
bioguided fractionation led to the isolation and identiﬁca-
tion of a major bioactive metabolite, spiroketalenol (SKE).
Quantitation and antimicrobial assays helped to high-
light the correlation existing between extracts' SKE content
and their corresponding activity against microorganisms.
The stability of SKE in cosmetic formulation was suc-
cessfully assessed at room temperature, so further opti-
mization of the natural ingredient took place. Extraction
assays enabled the selection of methanol as the best solvent
to enrich the S. chamaecyparissus extract in SKE. Dis-
colouration of the extract performed by adsorption of the
molecules responsible for the colouration on activated
carbon, led to further SKE enrichment of the S. chamaecy-
parissus extract.
Various cosmetic liquid supports adapted to the
cosmetic formulation and those displaying intrinsic anti-
microbial activity were successfully added during the
extraction process and highly active ingredients were
obtained.
Formulation assays were performed using the different
ingredients developed and subjected to challenge tests: the
cosmetic cream formulated with so-called ingredient 3
consisting of caprylyl glycol and the S. chamaecyparissus
extract (1:1) conforms to criteria A of the European Phar-
macopoeia and so, appears to be a good candidate for
future cosmetic use as a natural preservative.
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